Chaoju Eye Care Expands Investment in BOC Wealth Management Products
I'm PortAI, I can summarize articles.
Chaoju Eye Care Holdings Ltd. (HK:2219) announced that its subsidiary, Chaoju Medical Technology, has subscribed to BOC wealth management products worth RMB240 million, funded by surplus cash. This transaction is classified as a discloseable transaction under Hong Kong Stock Exchange rules and is expected to influence the company's financial strategy and cash management practices. The latest analyst rating for HK:2219 is a Hold with a price target of HK$3.00. Chaoju Eye Care operates in the eye care industry and has a market cap of HK$1.9B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments